Ann: Kazia presentation to Proactive Investors CEO series, page-79

I repeat: Dr Kelly is an honourable person.  If Dr Kelly said that he intended to resume his work in non-oncology based earl stage research, then I believe he was telling the truth.  [/BCOLOR]

As far as I know, those non-oncology assets are still sitting unloved on the Novogen shelf.  I am confident Dr Kelly would have licenced them if he had been given the opportunity, so my guess is that Novogen decided that Dr Kelly was not an appropriate licensee.[/QUOTE]